This indicates that the modest in vitro melanocyte proliferation advantage conferred by Ric-8A knockout (Figure 1c) was negated by loss of Gαq-Q209L oncoprotein folding capacity during in vivo tumor growth. Here, RIC8A is linked to neoplasm.